Latest Capital Raising And Funding News

QuickFee Limited has launched a A$1.5 million capital raising to fund expansion of its loan books in the US and Australia, following a quarter of record revenue and positive earnings before tax. The fintech also completed a major refinancing and revised its earnings guidance due to a credit impairment provision.

Ridley Corporation has successfully closed its retail entitlement offer, raising $26 million as part of a $125 million capital raise to fund its $300 million acquisition of Incitec Pivot’s fertiliser distribution business.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Tambourah Metals Ltd has announced a non-renounceable pro-rata entitlement offer to raise approximately $368,000, issuing new shares at $0.02 each with free-attaching options. The capital raise aims to fund exploration projects including Beatty Park Gold and Speewah North.

TruScreen Group Limited has announced a NZ$3 million capital raise to fund strategic growth initiatives across Asia and Africa, alongside repaying existing debt. The raise includes a placement and share purchase plan with free attaching options, signaling confidence in its expanding cervical cancer screening programs.

Greenwing Resources confirms NIO Inc.'s subsidiary did not exercise its call option on Andes Litio SA, while advancing exploration at the San Jorge Lithium Project in Argentina.

Orbminco Limited has entered a binding agreement to acquire the Majestic North Gold Project in Western Australia, boasting a JORC-compliant resource of nearly 40,000 ounces of gold. The company is raising A$0.88 million to support due diligence and exploration activities.

Rapid Lithium Limited has agreed to acquire two high-grade silver projects in New South Wales, adding nearly 35 million silver equivalent ounces to its portfolio. The deal, valued at A$6.5 million, signals a strategic diversification into critical minerals amid a robust silver market.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Midas Minerals has locked in $6.5 million through a two-tranche placement to fund its strategic acquisition and exploration of the Otavi Copper Project in Namibia, alongside advancing its broader project portfolio.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Bass Limited’s May 2025 AGM update highlights a strategic acquisition and capital raising to accelerate its emergence as a key Australian gas producer, focusing on Cooper Basin and Indonesian assets.